Connect with us

Technology

Osteotec Signs Exclusive Distribution Agreement with icotec ag to advance Spine Tumour Therapy in Great Britain

Published

on

NEWBURY, England, May 9, 2025 /PRNewswire/ — Osteotec, the market leading manufacturer and distributor of specialised medical devices, is pleased to announce an exclusive distribution agreement with icotec, the world leader of non-metallic spinal implants optimized for spine tumour therapy.

This collaboration, effective from May 8, marks a key milestone in Osteotec’s strategic growth, further expanding its spine product portfolio to provide physicians in Great Britain with advanced solutions that support improved patient outcomes.

Headquartered in Altstätten, Switzerland, icotec develops and manufactures innovative, radiolucent implants derived from BlackArmor® Carbon/PEEK material for the operative treatment of tumour diseases of the spine and other indications.

icotec’s BlackArmor® Carbon/PEEK material provides value in radiotherapy, enabling artifact-free CT/MRI images for accurate delineation of critical structures and accelerated dose planning, helping physicians improve diagnostic accuracy and deliver more effective treatment options for patients suffering with primary and metastatic spinal tumours.

“This partnership with icotec represents a significant step forward in our commitment to supporting physicians with innovative spinal solutions,” said Dean Stockwell, Osteotec Sales and Marketing Director.

“icotec’s innovative approach to the treatment of spinal oncology aligns with our mission to improve surgical outcomes and patient care. By adding icotec’s BlackArmor® implants to our growing spine portfolio, we are broadening the range of advanced tools available to physicians, enabling them to address the unique challenges associated with treating spinal tumours and other indications.”

The agreement solidifies Osteotec’s role as a supplier of spinal solutions in Great Britain, building on its established presence and expertise in supporting both NHS and private healthcare providers.

“We are excited to partner with Osteotec, a company renowned for its deep-rooted connections within the spine community and its dedication to improving patient care,” said Kurt Zoller, Chief Marketing Officer at icotec.

“Through this collaboration, we aim to make our BlackArmor® Carbon/PEEK implants more accessible to physicians across Great Britain, empowering them to deliver enhanced treatment options for patients with complex spinal conditions.”

About Osteotec

Osteotec is a manufacturer and distributor of medical devices headquartered in Newbury, UK, with offices in Dublin and Malmö. Established in 1993, Osteotec has been supplying into the NHS and private healthcare sectors for the past 31 years.

Osteotec manufactures and distributes the Osteotec Silicone Finger, ChiroKlip and the Concentric Bone Graft System and is a distributor for world-leading orthopaedic partners including Highridge Medical, SI-BONE, TriMed, Enovis and Cerapedics.

Media Contact:
Harriet Bawden
Marketing Manager
mkt@osteotec.com | 020 3011 5574
For more information, visit – www.osteotec.com

About icotec

icotec is the leading company for the treatment of spinal tumours and other indications with a new generation of high-tech implants. With its BlackArmor® Carbon/PEEK implants, icotec combines cutting-edge technologies and industry expertise to deliver innovative and reliable solutions for spine surgeons and their patients and is dedicated to advancing the field of spinal implantation.

With a track record of clinical success and a commitment to continuous innovation, icotec is poised to shape the future of spinal surgery. The comprehensive product portfolio has received FDA and CE clearance and is supported by numerous Key Opinion Leaders and spine surgery centres worldwide.

Media Contact:

John Clough
Vice President of Product Management and New Indications
John.clough@icotec-medical.com
For more information, visit www.icotec-medical.com

Logo – https://mma.prnewswire.com/media/2151731/5310260/Osteotec_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/osteotec-signs-exclusive-distribution-agreement-with-icotec-ag-to-advance-spine-tumour-therapy-in-great-britain-302451009.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Yon Raz-Fridman Joins Intrinsic Labs as Co-Founder and Partner

Published

on

By

Most AI companies are selling software. Intrinsic is deploying AI workers into the core operations of mid-market companies – and just brought in a serial tech entrepreneur to help the firm scale across the Heartland.

COLUMBUS, Ohio, April 30, 2026 /PRNewswire/ — Intrinsic Labs today announced that Yon Raz-Fridman has joined the firm as a Co-Founder and Partner.

Raz-Fridman has spent nearly two decades building across software, hardware, and platform businesses. Early in his career, he served as Chief of Staff to the President of Keter Group, a $1 billion-plus global consumer products manufacturer. He went on to co-found Kano, the award-winning educational computing company, and later founded Supersocial, the immersive gaming studio acquired by Super League Enterprises in 2025. He is a member of the World Economic Forum’s Technology Convergence Council.

He joins Intrinsic at a moment when mid-market companies are moving from AI experimentation to deployment. Intrinsic works with operators in logistics, construction, insurance, manufacturing, and industrial markets to deploy AI workers into the workflows that run the business – increasing throughput, reducing manual work, and expanding capacity without adding headcount.

The firm has built its reputation on practical deployments tied to real operating metrics. In one engagement with a national real estate brokerage, Intrinsic’s AI Accounting Agents reached 97% invoice coding accuracy, automated 90% of the AP workflow, and fully removed FTEs from the review flow.

“Yon understands what it takes to build and scale in the real world,” said Jon Slemp, Managing Partner at Intrinsic Labs. “Our clients aren’t buying flashy agents, they’re buying outcomes and reliable labor. They need agentic systems that take work off their teams, perform reliably, and produce measurable gains in throughput and capacity. That’s what we build.”

As Co-Founder, Raz-Fridman will oversee Intrinsic’s expansion – designing the channel relationships, institutional partnerships, and market positioning that take the firm from a proven Ohio model to the defining AI workforce platform for America’s industrial middle market.

“The companies that win over the next decade will be the ones that figure out how to staff AI into their operations and manage it like a workforce. Intrinsic is doing that work now, inside real businesses, tied to real outputs. The Heartland is exactly the right place to prove this model, and Intrinsic is exactly the right team to do it.” — Yon Raz-Fridman

About Intrinsic Labs LLC
Intrinsic Labs helps mid-market companies deploy AI workers into the workflows that run their business. The firm focuses on logistics, construction, insurance, manufacturing, and industrial markets, where manual work, fragmented systems, and labor constraints create clear opportunities for leverage. Intrinsic works with clients to put AI workers into production, tie them to operating KPIs, and help teams scale output without scaling headcount. https://www.intrinsic-labs.ai/  

About Team Yon LLC
Team Yon LLC is a management company founded by Yon Raz-Fridman that incubates new ventures, provides executive leadership, and makes strategic investments at the intersection of emerging technology and human advancement. Through Team Yon LLC, Raz-Fridman partners with founders and operators across healthcare, AI, and frontier technology – including his role as co-founder and Partner at Intrinsic Labs. https://teamyon.org

Media Contact:hello@intrinsic-labs.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/yon-raz-fridman-joins-intrinsic-labs-as-co-founder-and-partner-302756994.html

SOURCE Team Yon LLC

Continue Reading

Technology

Wipfli to complete CompliancePoint transaction and add associates, expanding capabilities

Published

on

By

MILWAUKEE, April 30, 2026 /PRNewswire/ — Wipfli, a top 25 national advisory and accounting firm, announced today it has entered into an agreement with CompliancePoint Inc., a provider of risk management services focused on information security, data privacy and regulatory compliance. 2 partners and 52 associates will join the firm as a result of the transaction.

Based in Duluth, Georgia, CompliancePoint brings specialization across cybersecurity, privacy and compliance, serving clients across a wide variety of industries. The addition strengthens Wipfli’s risk management offerings and expands its ability to help organizations navigate regulatory scrutiny, evolving cybersecurity threats and complex data protection requirements.

“Organizations today are under more pressure than ever to protect sensitive information and operate responsibly in an evolving regulatory environment,” said Kurt Gresens, CEO at Wipfli Advisory, LLC. “The team at CompliancePoint brings specialized experience and a strong, people-first approach that enhances how we support clients navigating today’s risk landscape.”

CompliancePoint has built its reputation on helping organizations manage risk across the full data lifecycle, with a holistic approach that recognizes how privacy, security and compliance intersect. The combined professional teams from CompliancePoint and Wipfli will deliver expanded, integrated advisory solutions designed to help clients proactively manage risk while supporting long-term growth and operational resilience.

“Wipfli shares our commitment to practical, client-focused solutions and long-term relationships,” said Greg Sparrow, CompliancePoint president. “Together, we’re expanding the resources available to our clients while continuing to deliver the specialized experience and trusted relationships they rely on.”

The addition of the CompliancePoint team also supports Wipfli’s continued investment in talent and innovation. CompliancePoint associates will join a national firm that emphasizes collaboration, professional development and meaningful client impact, while maintaining the specialized focus that has defined their work.

The transaction is expected to become effective on May 1st, 2026

About Wipfli

Wipfli is a leading national advisory and accounting firm with nearly 100 years of experience serving ambitious middle-market organizations. We understand our clients’ unique challenges and help them succeed on their terms through assurance, tax, advisory, outsourcing and technology services. With 3,000+ associates and global alliances, we combine national capabilities with local relationships. Wipfli operates under an alternative practice structure: Wipfli LLP, a licensed CPA firm, provides attest services, while Wipfli Advisory LLC, a non-CPA firm, delivers business advisory and non-attest services. Learn more at wipfli.com or contact Alicia O’Connell at alicia.oconnell@wipfli.com.

Media Contact

Alicia O’Connell
Wipfli
alicia.oconnell@wipfli.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wipfli-to-complete-compliancepoint-transaction-and-add-associates-expanding-capabilities-302756208.html

SOURCE Wipfli

Continue Reading

Technology

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Published

on

By

Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026

BOSTON, April 30, 2026 /PRNewswire/ — Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”) today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, beginning at 4:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo’s investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. The company offers autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo’s in-house autonomous lab is also available as a “cloud lab” through our Datapoints and Solutions contract research services. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com 

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2026-results-presentation-302757632.html

SOURCE Ginkgo Bioworks

Continue Reading

Trending